Part, Chapter, Paragraph
1 II, 5. 3. 5| Mortality and incidence data discussion~ ~All cancers (ICD-9 140 -
2 II, 5. 3. 6| 5.3.5 Survival data discussion~ ~EUROCARE is the largest
3 II, 5. 4. 4| 5.4.4. Data discussion~ ~Information shown in the
4 II, 5. 10. 4| 5.10.4. Data discussion~ ~An accurate estimation
5 II, 5. 15. 4| and to provide a forum for discussion, exchange of views and experience
6 II, 5. 15. 5| Recommendation now under discussion at the European Council,
7 II, 6. 4. 2| exchange of information and discussion about the coordination of
8 II, 7. 1 | and morbidity in the EU, a discussion of the evidence base for
9 II, 7. 1 | Recommendation (chapter “data discussion”), and a survey on available
10 II, 7. 4 | 7.4. Data discussion~ ~The survey of the previous
11 II, 8. 1. 4| cognitive testing. A first discussion with all MS on this module
12 II, 8. 2. 2| Evidence for Health Policy Discussion Paper No. 36). Available
13 III, 10. 1. 1| 1994). There is an ongoing discussion if sequential (non-integrated)
14 III, 10. 2. 1| the European Commission’s discussion paper for a health strategy”.
15 III, 10. 4. 2| needs to be prioritised for discussion and assessment. A set of
16 IV, 11. 1. 1| descriptive chapter, the discussion begins with a section on
17 IV, 11. 1. 1| methods. It then moves to a discussion of the trends in the provision
18 IV, 11. 6. 4| While there is growing discussion about the possibility of
19 IV, 11. 6. 5| the Enabling State. CASE Discussion Paper No. 41. London, Centre
20 IV, 12. 1 | Netherlands put on hold any discussion on extended health competences
21 IV, 12. 6 | one or two main topics for discussion and where all interested
22 IV, 12. 10 | is presently under public discussion.~Hypertension~ High~Circular
